BAFNA PHARMACEUTICALS LTD. | Scrip Code : 532989 | Quarter ending :December 2020 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | Yes | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 9 | 2,19,15,212 | 2,19,15,212 | 92.64 | 2,19,15,212 | 92.64 | 2,12,90,701 | 97.15 | 3,18,254 | 1.45 | 2,19,15,212 | - | - | - | (B) Public | 7,595 | 17,41,123 | 17,41,123 | 7.36 | 17,41,123 | 7.36 | | 0.00 | | 0.00 | 17,33,083 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 7,604 | 2,36,56,335 | 2,36,56,335 | 100.00 | 2,36,56,335 | 100.00 | 2,12,90,701 | 90.00 | 3,18,254 | 1.35 | 2,36,48,295 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|